TGFBR2 and neoplasm: We have previously reported that deletion of Tgfbr2, the gene encoding TGF-β receptor II (TβRII) in myeloid cells (Tgfbr2MyeKO) decreases macroscopic cancer metastasis through increased host anti-tumor immunity 47, 49.